Biologically relevant measure of a fertility hormone, Anti-Mullerian (AHM), can be accurately taken from a sample of human hair. AMH is presently measured in serum taken from a blood sample drawn intravenously, which is invasive and time-consuming. Hair samples are a more appropriate representation of hormone levels

TOP INSIGHT
Quantification of Anti-Mullerian hormone levels in the human hair makes it a non-invasive procedure, which reduces testing stress and offers a less expensive assay. It also makes the process accessible to many women and offers accurate results.
AMH is presently measured in serum taken from a blood sample drawn intravenously. The readings represent a measurement at a short moment in time and are relatively invasive to complete.
Now, however, a new study presented at the online Annual Meeting of ESHRE has tested the quantification of AMH from human hair and found it to be a less invasive and a "more appropriate representation of hormone levels" than from an "acute" source like serum. The results are presented this week in a poster from PhD student Sarthak Sawarkar, working in the laboratory of Professor Manel Lopez-Bejar in Barcelona, with collaborators from MedAnswers Inc in the USA.
The study, which still continues, now reports results from 152 women from whom hair and blood samples were routinely collected during hospital visits. AMH measured in serum from the same subjects was used to provide a control, as was an ultrasound count of developing follicles in the ovary (AFC) as a further measure of ovarian reserve.
"Biologically relevant" AMH levels were successfully detected in the hair samples, with levels declining with patient age, as expected. As ovarian reserve declines with age, so do AMH levels. The AMH levels from hair strongly correlated with both serum levels and AFC. It was also seen that the hair test was able to detect a wide range of AMH levels within individuals from a similar age cohort, suggesting a greater accuracy than from a single blood sample.
Among the other advantages of a hair test, the authors note that hormone levels are assessed non-invasively, which reduces testing stress and offers a less expensive assay. Testing can be done without visiting a clinic, and thus makes this type of test available to a broader range of women. "Finally," explains Mr Sawarkar, "as hair offers a look at the long-term accumulation of hormones, this measurement may allow a better understanding of an individual's hormone levels - unlike blood-based assays, which can only measure the hormone at the moment of the testing."
Commenting on the biology of the test, Mr Sawarkar explains that hormones are incorporated into the matrix of hair before the growing hair reaches the skin surface, thereby allowing an accumulating measurement of hormone concentration.
Source-Eurekalert
MEDINDIA




Email










